Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy
アクセス数 : 665 件
ダウンロード数 : 217 件
今月のアクセス数 : 0 件
今月のダウンロード数 : 1 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00047896
| File | |
| File | |
| File | |
| Title ( eng ) |
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy
|
| Title ( jpn ) |
HAICとソラフェニブで治療した進行肝細胞癌の予後不良症例の予測に治療4週後の血清HMGB1濃度が有用である
|
| Creator |
Masuda Kazuhiko
|
| Language |
eng
|
| Resource Type | doctoral thesis |
| Rights |
(c) The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
|
| Publish Type | Not Applicable (or Unknown) |
| Access Rights | open access |
| Source Identifier |
Masuda, K., Ono, A., Aikata, H. et al. J Gastroenterol (2018) 53: 107.
[DOI] https://doi.org/10.1007/s00535-017-1348-8
|
| Dissertation Number | 甲第7872号 |
| Degree Name | |
| Date of Granted | 2019-03-23 |
| Degree Grantors |
広島大学
|
